| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0004 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.53 | 0.0008 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.53 | 0.0009 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.73 | 0.005 |